2023
Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality A Meta-Analysis
Navarese E, Lansky A, Farkouh M, Grzelakowska K, Bonaca M, Gorog D, Raggi P, Kelm M, Yeo B, Umińska J, Curzen N, Kubica J, Wijns W, Kereiakes D. Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality A Meta-Analysis. JACC Cardiovascular Interventions 2023, 16: 1144-1156. PMID: 37225285, DOI: 10.1016/j.jcin.2023.02.030.Peer-Reviewed Original ResearchConceptsChronic coronary syndromeElective coronary revascularizationNoncardiac mortalityMedical therapyCoronary revascularizationTrial sequential analysisCumulative Z-curveRate ratioA Meta-AnalysisRandom-effects modelMeta-analysis findingsCoronary syndromeISCHEMIA trialRandomized trialsTrial evidenceRevascularizationTreatment groupsPrespecified endpointsMeta-analysisPatientsMortalityFutility boundariesDeath rateTrialsTreatment effects
2021
Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population
Chatterjee S, Fanaroff AC, Parzynski C, Curtis J, Kolansky DM, Maddox TM, Mukherjee D, Yeh RW, Giri J. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population. JACC Cardiovascular Interventions 2021, 14: 2344-2349. PMID: 34736733, DOI: 10.1016/j.jcin.2021.08.047.Peer-Reviewed Original ResearchConceptsStable ischemic heart diseasePercutaneous coronary interventionISCHEMIA trialSIHD patientsCoronary interventionNational Cardiovascular Data Registry CathPCI RegistryStudy periodHospital mortality rateHigh-risk featuresProportion of patientsTrial inclusion criteriaComparison of patientsIschemic heart diseaseCross-sectional analysisIschemic burdenMedian hospitalAngina symptomsCathPCI RegistryTrial populationComparator groupEnrollment criteriaMyocardial infarctionHeart diseaseU.S. patientsInclusion criteriaContemporary Management of Stable Coronary Artery Disease ― Implications of the ISCHEMIA Trial ―
Kohsaka S, Fukushima K, Watanabe I, Manabe S, Niimi N, Gatate Y, Sawano M, Nakano S. Contemporary Management of Stable Coronary Artery Disease ― Implications of the ISCHEMIA Trial ―. Circulation Journal 2021, 85: 1919-1927. PMID: 34148929, DOI: 10.1253/circj.cj-21-0345.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseAcute coronary syndromeStable coronary artery diseaseRecent large-scale clinical trialsLarge-scale clinical trialsCornerstone of managementInvasive coronary angiographyDifferent clinical entitiesUrgent revascularizationCoronary syndromeArtery diseaseCoronary angiographyMedical therapyISCHEMIA trialClinical entityClinical trialsDiagnostic pathwayLeading causePretest probabilityContemporary managementOptimal timingRevascularizationTrialsDisease implicationsMorbidity
2020
Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention
Niimi N, Sawano M, Ikemura N, Nagai T, Nakano S, Shoji S, Shiraishi Y, Ueda I, Numasawa Y, Suzuki M, Noma S, Fukuda K, Kohsaka S. Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention. Journal Of Clinical Medicine 2020, 9: 2889. PMID: 32906673, PMCID: PMC7564619, DOI: 10.3390/jcm9092889.Peer-Reviewed Original ResearchPercutaneous coronary interventionNon-eligible patientsComparative Health EffectivenessSevere ischemiaEligible patientsBaseline characteristicsCoronary interventionRCT patientsStable ischemic heart disease patientsHealth effectivenessMajor adverse cardiac eventsIschemic heart disease patientsRole of revascularizationAdverse cardiac eventsEarly invasive strategyInvasive Approaches (ISCHEMIA) trialHeart disease patientsInternational studiesSIHD patientsMulticenter registryPCI patientsCardiac eventsISCHEMIA trialDisease patientsBaseline cohort
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply